Back to BARCLAYS PLC BARCLAYS PLC

AQSTAQST
25 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in AQUESTIVE THERAPEUTICS INC

Yes. Barclays holds 996,665 shares of AQST (Aquestive Therapeutics), worth $4.1M, as of its Q2 2026 13F filing. It increased the position by 197,502 shares (+24.7%) from Q1 2026. Barclays has held AQST since Q2 2024, across 9 quarterly 13F filings.

Current Value

$4.1M

Current Shares

996,665

Total Value Change

+$4.1M

Total Shares Change

+990,804

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
996,665
+24.7%
$4.1M0.0%$4.16
33
2026-Q1
Increased
799,163
+134.5%
$3.3M0.0%$4.15
43
2025-Q4
Increased
340,807
+158.7%
$2.2M0.0%$6.46
42
2025-Q3
Decreased
131,758
-14.3%
$736,5270.0%$5.59
0
2025-Q2
Increased
153,828
+85.4%
$509,1710.0%$3.31
38
2025-Q1
Decreased
82,957
-30.1%
$240,5750.0%$2.90
0
2024-Q4
Increased
118,711
+19.5%
$422,6110.0%$3.56
28
2024-Q3
Increased
99,312
+285.4%
$494,5740.0%$4.98
39
2024-Q2
New
25,770
-
$67,0020.0%$2.60
32
2023-Q4
Exited
0
-100.0%
$00.0%$2.02
0
2023-Q3
New
7,144
-
$10,9300.0%$1.53
26
2022-Q2
Exited
0
-100.0%
$00.0%$0.64
0
2022-Q1
Unchanged
24,829
0.0%
$65,0000.0%$2.61
0
2021-Q4
Decreased
24,829
-11.1%
$97,0000.0%$3.89
0
2021-Q3
Decreased
27,926
-11.0%
$122,0000.0%$4.36
0
2021-Q2
Increased
31,382
+88.9%
$125,0000.0%$3.97
35
2021-Q1
Increased
16,612
+159.0%
$86,0000.0%$5.20
24
2020-Q4
Decreased
6,415
-29.4%
$34,0000.0%$5.35
0
2020-Q3
Decreased
9,080
-71.9%
$43,0000.0%$4.86
0
2020-Q2
New
32,342
-
$156,0000.0%$4.86
31
2020-Q1
Exited
0
-100.0%
$00.0%$2.19
0
2019-Q4
Decreased
159
-80.4%
$1,0000.0%$5.82
0
2019-Q3
Increased
811
+93.1%
$2,0000.0%$3.18
12
2019-Q2
Decreased
420
-92.8%
$2,0000.0%$4.20
0
2019-Q1
New
5,861
-
$40,0000.0%$6.91
31

Other major holders of AQST: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used